Sandra Pelka

Sandra Pelka

Auto-generated profile, based on publicly available information

Sandra Pelka

Institute for Aging Studies, Albert Einstein College of Medicine, Bronx, NY 10461

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CRCara A. Reynolds
Cara A. Reynolds
SPSandra Pelka
Sandra Pelka
FGFloralba Gjergjova
Floralba Gjergjova
ITInmaculada Tasset
Inmaculada Tasset
RKRabia R. Khawaja
Rabia R. Khawaja
FMFernando Macian
Fernando Macian
Chaperone-mediated autophagy (CMA) is a selective form of autophagy that contributes to the maintenance of cellular homeostasis. CMA activity declines with age in most tissues and systems, including the immune system, due to a reduction in levels of lysosome-associated membrane protein type 2A (LAMP2A), an essential CMA component. In this study, we show that overexpressing a copy of hLAMP2A within T cells since middle-age can prevent some of their age-associated loss of function. Our data support the idea that preserving LAMP2A expression with age through genetic means leads to enhanced proliferative responses, decreased number of regulatory T cell populations, and down-regulated expression of inhibitory receptors by T cells. During aging, elevated numbers of these immunosuppressive T cell populations significantly contribute to the age-associated downregulation of T cell responses. Using comparative proteomics, we confirm that preservation of CMA activity in old mice prevents age-related changes in both the resting and the activated T cell proteome. We also explore the effect of using first-in-class small molecule activators of CMA and demonstrate improved T cell response upon their administration to old mice. We conclude that sustaining CMA activity constitutes a potentially viable therapeutic approach to improving T cell function with age.